Regulation of the neuroinflammatory response in autoimmune uveitis
Regulation of the neuroinflammatory response in autoimmune uveitis
批准号:
10527371
负责人:
MEREDITH GREGORY-KSANDER
金额:
$42.5万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
已结题
起止时间:
2021-01-01 至 2024-11-30
关键词:
AblationAccountingAdoptive TransferAnti-CD47AntibodiesAntigen PresentationAntigen TargetingAntigen-Presenting CellsAntigensAstrocytesAutoantigensAutoimmuneAutoimmune ResponsesBlindnessBlood-Retinal BarrierCD47 geneCellsCentral Nervous SystemChronicDataDevelopmentDiseaseDisease ProgressionEndothelial CellsEtiologyExperimental ModelsEyeGoalsImmuneImmune responseImmune systemImmunizationImmunosuppressionInfiltrationInflammationInflammatoryInflammatory ResponseInjuryKineticsLeukocytesMHC Class II GenesMaintenanceMediatingMicrogliaModelingMuller&aposs cellMusOptic NervePTPNS1 genePathogenesisPatientsPhagocytosisPhenotypePhotoreceptorsPopulationPrevalenceProductionRNA SequencesReactionRegulationReportingResearchRetinaRoleSarcoidosisSecondary toSyndromeSystemic diseaseT-LymphocyteTestingTimeTissuesTransgenic MiceTransgenic OrganismsUveitisUveomeningoencephalitic SyndromeVisionVisual impairmentWorkautoimmune uveitisautoinflammatoryautoreactivitycell typecytokineimmune cell infiltrateinnovationmouse modelneovascularneuralneuroinflammationpharmacologicpreventreceptorrecruitresponsesingle-cell RNA sequencing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Research Abstract: Autoimmune uveitis is a serious sight-threatening condition defined by an autoreactive
immune response against the retina and uveal tissues. In autoimmune uveitis, the retina and uveal tissues
become a target of autoreactive immune cells, which leads to irreversible neural damages and can progress to
significant visual impairment. Since the retina is a so-called “immune privileged” tissue protected by blood-
retinal barrier, how immune cells gain entry into the retina and what antigen presenting cell (APC) populations
are involved in local antigen presentation have been a long discussion. This proposal describes aims to
elucidate an innovative mechanism whereby retinal microglia mediate autoreactive immune cell entry into the
retina. Microglia are the resident immune cells of the central nervous system, including the retina, and function
in the homeostatic maintenance of the neuro-retinal microenvironment. The role and function of microglia in
disease progression is not well understood due to their multiple phenotypes and/or different stages of
activation that are associated with either harmful or beneficial effects in disease pathogenesis.
Our recent work demonstrated that microglial depletion inhibits development of EAU and that microglia are
essential to disease induction. Interestingly, retinal microglia are significantly activated in response to EAU
disease induction, quickly localizing to the retinal vasculature. However, our data indicated that microglia do
not function as APCs in disease initiation, but in fact function to facilitate infiltration of a variety of circulating
immune cells into the neuroretina. Our data highly suggested that microglia are key population that initiates
blood-retinal barrier breakdown and that the circulating APCs and T cells that enter the retina trigger the
subsequent vision altering auto-inflammatory response. However, the mechanisms by which this occurs
remains unknown.
In this proposal, we will elucidate the mechanism by which autoreactive immune cells gain entry into the retina
and how the subsequent autoimmune response develops during disease progression in a mouse model of
experimental autoimmune uveitis (EAU). We will begin by defining the initiating APC populations in EAU and
the contribution of microglial expression of MHC-II during EAU disease progression. Moreover, we will identify
the activation and kinetics of retinal microglia and infiltrating immune cells in EAU induction by using a single
cell RNA sequence profiling. Lastly, we will define the role of SIRPalpha/CD47, an immune axis that is highly
regulated in EAU and that functions in phagocytosis initiation and immune cell reactivity. Understanding the
mechanism by which microglia initiate autoimmune uveitis will likely open new avenues of therapy for this
disease as well as other blinding neovascular ophthalmic diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10374484
-
项目类别:
-
资助金额:$61.96万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10867990
-
项目类别:
-
资助金额:$4.36万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Cleavage regulates ocular homeostasis and glaucoma
-
批准号:10550147
-
项目类别:
-
资助金额:$60.02万
-
财政年份:2022
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10320063
-
项目类别:
-
资助金额:$41.23万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of the neuroinflammatory response in autoimmune uveitis
-
批准号:10115860
-
项目类别:
-
资助金额:$42.5万
-
财政年份:2021
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Uncoupling caspase 8-mediated-apotosis from caspase 8-mediated-inflammation in glaucoma.
-
批准号:9919567
-
项目类别:
-
资助金额:$24.63万
-
财政年份:2019
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8385057
-
项目类别:
-
资助金额:$30.02万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Regulation of vascular leakage in age related macular degeneration
-
批准号:8534134
-
项目类别:
-
资助金额:$21.67万
-
财政年份:2012
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8237645
-
项目类别:
-
资助金额:$48.5万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8389866
-
项目类别:
-
资助金额:$46.08万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Neurotoxicity and neuroprotection in the DBA/2J spontaneous model of glaucoma
-
批准号:8581345
-
项目类别:
-
资助金额:$47.53万
-
财政年份:2011
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7534765
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6857036
-
项目类别:
-
资助金额:$41.7万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7342074
-
项目类别:
-
资助金额:$37.3万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:6986096
-
项目类别:
-
资助金额:$38.28万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Soluble Fas Ligand and Ocular Immune Privilege
-
批准号:7171789
-
项目类别:
-
资助金额:$38.06万
-
财政年份:2004
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6525174
-
项目类别:
-
资助金额:$4.62万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6641246
-
项目类别:
-
资助金额:$4.94万
-
财政年份:2002
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Fas Ligand Regulation of Ocular Innate Immunity
-
批准号:6405260
-
项目类别:
-
资助金额:$4.02万
-
财政年份:2001
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
Role of Toxins in Endophthalmitis
-
批准号:8288200
-
项目类别:
-
资助金额:$41.7万
-
财政年份:1989
-
负责人:MEREDITH GREGORY-KSANDER
-
依托单位:
海外基金